
© 2025 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
16,660 | 16,680 | 17.04. | |
16,642 | 16,672 | 17.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings? | ||
Do | Ergebnissaison, Zollstreit, iPhone-Auslieferungen, Tesla-Dilemma, Intuitive u.a. - Calling USA | ||
Do | Ipsen's liver disease drug Iqirvo off to promising launch in battle with Gilead's Livdelzi | ||
Mi | Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now? | ||
Di | Gilead Sciences: Advancing Oncology Care Through Gilead's Research Scholars Program | NORTHAMPTON, MA / ACCESS Newswire / April 15, 2025 / As a medical oncologist who has practiced in three different countries, Dr. Maria Alice Franzoi is well acquainted with various healthcare systems... ► Artikel lesen |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
16:09 | LGA 1954 folgt LGA 1851: Intel wechselt mit Nova Lake schon wieder den CPU-Sockel | ||
11:31 | Prediction: 2 Stocks That Will Be Worth More Than Intel 5 Years From Now | ||
09:43 | Unglaubliche Prognose für Montag setzt Intel Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
Fr | Intel Corporation (INTC) Faces AI Export Challenges to China Under New U.S. Licensing Rules | ||
Fr | Strategic Reset Begins: Intel Sells Controlling Stake in Altera |
Unternehmen / Aktien | Kurs | % |
---|---|---|
GILEAD SCIENCES INC | 91,99 | +0,08 % |
INTEL CORPORATION | 16,660 | +0,06 % |